3 completed, 1 unknown. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Unknown 1 |
| Phase 2 | 3 | Completed 2, Unknown 1 |
Follow treosulfan: new trials by email Literature Review of treosulfan trials Research Report on treosulfan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics Treosulfan, Fludarabine - Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS) | Phase 1 | Completed | medac GmbH | 20 | 2024-02-01 | 2026-05-20 |
| Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial Lenalidomide, Pioglitazone, dexamethasone, treosulfan - Multiple Myeloma | Phase 1 / Phase 2 | Unknown | University of Regensburg | 54 | 2009-10-01 | 2012-05-30 |
| Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome fludarabine, treosulfan, allogeneic blood or bone marrow transplantation - Leukemia, Myelodysplastic Syndromes | Phase 1 / Phase 2 | Completed | OHSU Knight Cancer Institute | 60 | 2005-06-01 | 2012-06-01 |
| Dose-range Finding Treosulfan-based Conditioning Treosulfan - Hematological Malignancies | Phase 1 / Phase 2 | Completed | medac GmbH | 56 | 2001-11-01 | 2026-08-12 |
Leukemia, Myeloid, Acute (2) · Myelodysplastic Syndromes (2) · Hematologic Neoplasms (1) · Leukemia (1) · Multiple Myeloma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1)
medac GmbH (2) · OHSU Knight Cancer Institute (1) · University of Regensburg (1)
Germany (2) · United States (2) · Finland (1) · Poland (1) · Sweden (1)
Albrecht Reichle, Professor (1) · Eneida Nemecek, MD (1) · Mathias Freund, MD (1) · Ute Eckenbach (1)